AU2002333373A1 - Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof - Google Patents

Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof

Info

Publication number: AU2002333373A1
Authority: AU; Australia
Prior art keywords: benzothiepine; active substances; dioxide derivatives; combined preparations; preparations
Prior art date: 2001-08-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002333373A

Other versions

AU2002333373B2 (en

Inventor

Wendelin Frick

Heiner Glombik

Werner Kramer

Hans-Ludwig Schaefer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis Deutschland GmbH

Original Assignee

Sanofi Aventis Deutschland GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-22

Filing date

2002-08-09

Publication date

2003-06-05

2001-08-22 Priority claimed from DE10140169A external-priority patent/DE10140169A1/en

2001-08-31 Priority claimed from DE10142456A external-priority patent/DE10142456A1/en

2002-08-09 Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH

2002-08-09 Priority claimed from PCT/EP2002/008908 external-priority patent/WO2003018024A1/en

2003-06-05 Publication of AU2002333373A1 publication Critical patent/AU2002333373A1/en

2005-12-15 Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH

2006-12-14 Application granted granted Critical

2006-12-14 Publication of AU2002333373B2 publication Critical patent/AU2002333373B2/en

2022-08-09 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE10140169A DE10140169A1 (en)	2001-08-22	2001-08-22	Synergistic mixture containing benzothiepine derivative, useful for treating or preventing disorders of lipid metabolism, includes e.g. cholesterol resorption inhibitor
DE10140169.8		2001-08-22
DE10142456.6		2001-08-31
DE10142456A DE10142456A1 (en)	2001-08-31	2001-08-31	Synergistic mixture containing benzothiepine derivative, useful for treating or preventing disorders of lipid metabolism, includes e.g. cholesterol resorption inhibitor
PCT/EP2002/008908 WO2003018024A1 (en)	2001-08-22	2002-08-09	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof

Publications (2)

Publication Number	Publication Date
AU2002333373A1 true AU2002333373A1 (en)	2003-06-05
AU2002333373B2 AU2002333373B2 (en)	2006-12-14

Family

ID=26009944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002333373A Ceased AU2002333373B2 (en)	2001-08-22	2002-08-09	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof

Country Status (29)

Country	Link
US (2)	US20030158119A1 (en)
EP (1)	EP1425018B1 (en)
JP (1)	JP2005501861A (en)
KR (1)	KR20040032937A (en)
CN (1)	CN1655792A (en)
AR (1)	AR035285A1 (en)
AT (1)	ATE411802T1 (en)
AU (1)	AU2002333373B2 (en)
BR (1)	BR0212031A (en)
CA (1)	CA2457976A1 (en)
CO (1)	CO5560550A2 (en)
DE (1)	DE50212937D1 (en)
HN (1)	HN2002000235A (en)
HR (1)	HRP20040171A2 (en)
HU (1)	HUP0401318A3 (en)
IL (1)	IL160474A0 (en)
MA (1)	MA26317A1 (en)
MX (1)	MXPA04001328A (en)
NO (1)	NO20040702L (en)
NZ (1)	NZ531293A (en)
OA (1)	OA12654A (en)
PA (1)	PA8553201A1 (en)
PE (1)	PE20030361A1 (en)
PL (1)	PL366851A1 (en)
RS (1)	RS11104A (en)
RU (1)	RU2297222C2 (en)
TN (1)	TNSN04034A1 (en)
UY (1)	UY27419A1 (en)
WO (1)	WO2003018024A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
SI1413331T1 (en)	2001-01-26	2008-02-29	Schering Corp	Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications
RS50406B (en)	2001-01-26	2009-12-31	Schering Corporation,	USE OF SUBSTITUTED AZETIDINONE UNITS FOR TREATMENT OF SITOSTEROLEMIA
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
MXPA04002573A (en)	2001-09-21	2004-06-18	Schering Corp	Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors.
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
EP1562582A1 (en)	2002-11-06	2005-08-17	Schering Corporation	Cholesterol absorption inhibitors for the treatment of demyelination
JP4589919B2 (en)	2003-03-07	2010-12-01	シェーリングコーポレイション	Substituted azetidinone compounds, their formulations and uses for the treatment of hypercholesterolemia
US7192944B2 (en)	2003-03-07	2007-03-20	Schering Corp.	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
ES2311806T3 (en)	2003-03-07	2009-02-16	Schering Corporation	AZETIDINONA COMPOSITE SUBSTITUTED, FORNULATIONS AND USES OF THE SAME FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA.
DE102006053637B4 (en) *	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Novel fluorine-substituted 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use
JP2010509252A (en)	2006-11-14	2010-03-25	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	Novel 1,4-benzothiepine-1,1-dioxide derivatives having improved properties, processes for their preparation, drugs containing the above compounds and their use
DE102006053635B4 (en)	2006-11-14	2011-06-30	Sanofi-Aventis Deutschland GmbH, 65929	Novel benzyl-substituted 1,4-benzothiepine-1,1-dioxide derivatives, drugs containing these compounds and their use
DE102006053636B4 (en)	2006-11-14	2008-09-18	Sanofi-Aventis Deutschland Gmbh	New cyclohexyl substituted 1,4-benzothiepine 1,1-dioxide derivatives and their use
WO2010062861A2 (en)	2008-11-26	2010-06-03	Satiogen Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of obesity and diabetes
EP2575821B1 (en) *	2010-05-26	2015-08-12	Satiogen Pharmaceuticals, Inc.	Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
EP2765855A4 (en) *	2011-10-12	2015-03-25	Merck Sharp & Dohme	PHARMACEUTICAL COMPOSITIONS INHIBITING DISMUTATION
JP6217938B2 (en)	2011-10-28	2017-10-25	ルメナファーマシューティカルズエルエルシー	Bile acid recirculation inhibitors for the treatment of cholestatic liver disease in children
CA2852957C (en)	2011-10-28	2020-08-04	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
WO2014144650A2 (en)	2013-03-15	2014-09-18	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
EP2968262A1 (en)	2013-03-15	2016-01-20	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease
KR20150079373A (en)	2013-12-30	2015-07-08	한미약품 주식회사	Composite formulation for oral administration comprising ezetimibe and rosuvastatin
BR112021015815A2 (en)	2019-02-12	2022-01-18	Mirum Pharmaceuticals Inc	Methods to treat cholestasis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2663336B1 (en)	1990-06-18	1992-09-04	Adir	NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
WO1997026265A1 (en)	1996-01-17	1997-07-24	Novo Nordisk A/S	Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
EP1826216A1 (en)	1996-08-30	2007-08-29	Novo Nordisk A/S	Glp-1 derivatives
ATE246190T1 (en)	1996-12-31	2003-08-15	Reddys Lab Ltd Dr	HETEROCYCLIC COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE IN THE TREATMENT OF DIABETIS AND RELATED DISEASES
DE19726167B4 (en)	1997-06-20	2008-01-24	Sanofi-Aventis Deutschland Gmbh	Insulin, process for its preparation and pharmaceutical preparation containing it
BR9810592A (en)	1997-07-16	2000-09-12	Novo Nordisk As	Compound, processes for preparing a compound, for treating or preventing diseases of the endocrine system and for the manufacture of a drug, pharmaceutical composition, and, use of a compound
CO4970713A1 (en)	1997-09-19	2000-11-07	Sanofi Synthelabo	DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19825804C2 (en) *	1998-06-10	2000-08-24	Aventis Pharma Gmbh	1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation and medicaments containing these compounds
DE19845405C2 (en)	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Aryl-substituted propanolamine derivatives and their use
NZ512532A (en) *	1998-12-23	2003-12-19	G	Combinations for treating cardiovascular diseases like hypercholesterolemia and atherosclerosis
GB9900416D0 (en)	1999-01-08	1999-02-24	Alizyme Therapeutics Ltd	Inhibitors
JP2002542245A (en)	1999-04-16	2002-12-10	ノボノルディスクアクティーゼルスカブ	Substituted imidazoles, their manufacture and use
JP2002543200A (en)	1999-04-30	2002-12-17	ニューロゲンコーポレイション	9H-pyrimido [4,5-b] indole derivative: CRF1 specific ligand
GB9911863D0 (en)	1999-05-21	1999-07-21	Knoll Ag	Therapeutic agents
EP1194146B1 (en)	1999-06-18	2006-07-19	Merck & Co., Inc.	Arylthiazolidinedione and aryloxazolidinedione derivatives
WO2001009111A1 (en)	1999-07-29	2001-02-08	Eli Lilly And Company	Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
SK2682002A3 (en)	1999-09-01	2002-07-02	Aventis Pharma Gmbh	Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
AU5257401A (en)	2000-04-28	2001-11-12	Asahi Chemical Ind	Novel bicyclic compounds
EP1280777B1 (en)	2000-05-11	2005-11-23	Bristol-Myers Squibb Company	Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
AU6497701A (en)	2000-05-30	2001-12-11	Merck & Co Inc	Melanocortin receptor agonists
IL156552A0 (en) *	2000-12-21	2004-01-04	Aventis Pharma Gmbh	Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use

2002
- 2002-08-09 WO PCT/EP2002/008908 patent/WO2003018024A1/en not_active Ceased
- 2002-08-09 NZ NZ531293A patent/NZ531293A/en not_active IP Right Cessation
- 2002-08-09 AT AT02796213T patent/ATE411802T1/en not_active IP Right Cessation
- 2002-08-09 MX MXPA04001328A patent/MXPA04001328A/en active IP Right Grant
- 2002-08-09 RS YU11104A patent/RS11104A/en unknown
- 2002-08-09 EP EP02796213A patent/EP1425018B1/en not_active Expired - Lifetime
- 2002-08-09 IL IL16047402A patent/IL160474A0/en unknown
- 2002-08-09 HU HU0401318A patent/HUP0401318A3/en unknown
- 2002-08-09 HR HR20040171A patent/HRP20040171A2/en not_active Application Discontinuation
- 2002-08-09 AU AU2002333373A patent/AU2002333373B2/en not_active Ceased
- 2002-08-09 CN CNA028163109A patent/CN1655792A/en active Pending
- 2002-08-09 PL PL02366851A patent/PL366851A1/en not_active Application Discontinuation
- 2002-08-09 CA CA002457976A patent/CA2457976A1/en not_active Abandoned
- 2002-08-09 JP JP2003522542A patent/JP2005501861A/en active Pending
- 2002-08-09 BR BR0212031-3A patent/BR0212031A/en not_active IP Right Cessation
- 2002-08-09 KR KR10-2004-7002440A patent/KR20040032937A/en not_active Ceased
- 2002-08-09 DE DE50212937T patent/DE50212937D1/en not_active Expired - Lifetime
- 2002-08-09 RU RU2004108119/15A patent/RU2297222C2/en not_active IP Right Cessation
- 2002-08-09 OA OA1200400057A patent/OA12654A/en unknown
- 2002-08-16 PE PE2002000742A patent/PE20030361A1/en not_active Application Discontinuation
- 2002-08-20 UY UY27419A patent/UY27419A1/en unknown
- 2002-08-20 PA PA20028553201A patent/PA8553201A1/en unknown
- 2002-08-20 AR ARP020103125A patent/AR035285A1/en not_active Application Discontinuation
- 2002-08-20 HN HN2002000235A patent/HN2002000235A/en unknown
- 2002-08-22 US US10/225,841 patent/US20030158119A1/en not_active Abandoned
2003
- 2003-11-03 US US10/699,967 patent/US7179792B2/en not_active Expired - Lifetime
2004
- 2004-02-11 MA MA27524A patent/MA26317A1/en unknown
- 2004-02-18 NO NO20040702A patent/NO20040702L/en not_active Application Discontinuation
- 2004-02-19 CO CO04014418A patent/CO5560550A2/en not_active Application Discontinuation
- 2004-02-20 TN TNP2004000034A patent/TNSN04034A1/en unknown

Publication	Publication Date	Title
AU2002333373A1 (en)	2003-06-05	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
HRP20040171A2 (en)	2004-10-31	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU2002306269A1 (en)	2003-05-15	N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001290257A1 (en)	2002-06-27	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en)	2003-05-01	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001256184A1 (en)	2001-09-24	6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU3076700A (en)	2000-08-18	2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
IL159086A0 (en)	2004-05-12	3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
AU2300699A (en)	1999-08-30	Amidino derivatives and drugs containing the same as the active ingredient
AU2001277741A1 (en)	2002-05-23	2-aminopyridine compounds and use thereof as drugs
AU2002238947A1 (en)	2003-03-27	Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
AU2001269474A1 (en)	2002-04-18	Phenylpyridazine Compounds and Medicines Containing the Same
AU3053199A (en)	1999-10-25	Fused thiophene derivatives and drugs containing the same as the active ingredient
AU2001264042A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
ZA200007415B (en)	2002-04-02	Amino acid derivatives and drugs containing the same as the active ingredient.
AU6635800A (en)	2001-03-13	Pyridomorphinans, thienomoprhinans and use thereof
AU1650401A (en)	2001-06-25	Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU2001277738A1 (en)	2002-05-23	Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2001227084A1 (en)	2001-08-07	N-arylhydrazide compounds and use thereof as drugs
AU1650501A (en)	2001-06-12	1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
AU2001294240A1 (en)	2002-04-22	2,2-diphenylbutanamide derivatives and medicines containing the same
AU2001274535A1 (en)	2002-03-14	Hydroxyformamidine derivatives and medicines containing the same
AU2023801A (en)	2001-06-25	Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient
HUP0104238A3 (en)	2003-05-28	Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU1053501A (en)	2001-05-14	Polyazanaphthalene compound and medicinal use thereof